Sat, Apr 20, 2024
Volume 15, Issue 6 (Special issue (Nov-Dec) 2021)
mljgoums 2021, 15(6): 23-30 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Chakroun A, Baccouche H, Mahjoub S, Ben Romdhane N. Assessment of Peripheral Blood Lymphocytosis in Adults: Determination of Thresholds for Differential Diagnosis between Clonal and Reactive Lymphocytosis. mljgoums 2021; 15 (6) :23-30
URL: http://mlj.goums.ac.ir/article-1-1411-en.html
URL: http://mlj.goums.ac.ir/article-1-1411-en.html
1- La Rabta University Hospital, Hematology Department, La Rabta University Hospital, Tunis, Tunisia And Faculty of Medicine of Tunis, Tunis University El Manar, Tunis, Tunisia , aya.chakroun@fmt.utm.tn
2- La Rabta University Hospital, Hematology Department, La Rabta University Hospital, Tunis, Tunisia And Faculty of Medicine of Tunis, Tunis University El Manar, Tunis, Tunisia
2- La Rabta University Hospital, Hematology Department, La Rabta University Hospital, Tunis, Tunisia And Faculty of Medicine of Tunis, Tunis University El Manar, Tunis, Tunisia
Abstract: (1978 Views)
Background and objectives: Differential diagnosis between clonal lymphocytosis (CL) and reactive lymphocytosis (RL) is often established through blood smear examination but with some limitations. We aimed to evaluate ability of clinical data and extended-cells blood count (CBC) parameters to discriminate CL from RL and to establish a decision-making algorithm for moderate lymphocytosis in adults.
Methods: A total of 85 samples were collected from adults with absolute lymphocytescount of >5G/l. The samples were divided into RL group (n=34) and newly diagnosed CL group (n=51).Demographic data, CBC parameters including high fluorescence lymphocytes cells percentage (HFLC%) and abnormal lymphocytes or blasts (’AbnLym/BL’’) morphological flag were evaluated for each study group. New threshold for discriminating parameters were determined using receiver operating characteristic (ROC) curves and used in an algorithm for moderate lymphocytosis.
Results: Age, high lymphocytes count and the presence of the ’AbnLym/BL’’ flag and low HFLC% were predictor of malignant lymphocytosis. Age threshold of 62.5 years and absolute lymphocytes count of > 10.47 G/l were highly effective in CL detection with area under the ROC curve of 0.9 and 0.99, respectively. In addition, HFLC% showed an area under the ROC curve of 0.71. Considering ALC threshold of 10.47 G/l alone, a sensitivity of 96.7% and a specificity of 100 % were achieved. For moderate lymphocytosis ranging between 5 and 10.47G/l, no false positive or negative result was detected when we considered both the proposed ALC and age cut-offs.
Conclusion: A combination threshold for ALC and age appears to be helpful for screening CL, especially in moderate lymphocytosis for both laboratory and clinical routine practice.
Methods: A total of 85 samples were collected from adults with absolute lymphocytescount of >5G/l. The samples were divided into RL group (n=34) and newly diagnosed CL group (n=51).Demographic data, CBC parameters including high fluorescence lymphocytes cells percentage (HFLC%) and abnormal lymphocytes or blasts (’AbnLym/BL’’) morphological flag were evaluated for each study group. New threshold for discriminating parameters were determined using receiver operating characteristic (ROC) curves and used in an algorithm for moderate lymphocytosis.
Results: Age, high lymphocytes count and the presence of the ’AbnLym/BL’’ flag and low HFLC% were predictor of malignant lymphocytosis. Age threshold of 62.5 years and absolute lymphocytes count of > 10.47 G/l were highly effective in CL detection with area under the ROC curve of 0.9 and 0.99, respectively. In addition, HFLC% showed an area under the ROC curve of 0.71. Considering ALC threshold of 10.47 G/l alone, a sensitivity of 96.7% and a specificity of 100 % were achieved. For moderate lymphocytosis ranging between 5 and 10.47G/l, no false positive or negative result was detected when we considered both the proposed ALC and age cut-offs.
Conclusion: A combination threshold for ALC and age appears to be helpful for screening CL, especially in moderate lymphocytosis for both laboratory and clinical routine practice.
Research Article: Original Paper |
Subject:
Laboratory hematology
Received: 2021/07/27 | Accepted: 2021/08/30 | Published: 2021/10/18 | ePublished: 2021/10/18
Received: 2021/07/27 | Accepted: 2021/08/30 | Published: 2021/10/18 | ePublished: 2021/10/18
References
1. Shiftan TA, Mendelsohn J. The circulating "atypical" lymphocyte. Human Pathology. 1978; 9(1): 51-61. [View at Publisher] [DOI:10.1016/S0046-8177(78)80007-0] [PubMed] [Google Scholar]
2. Macintyre EA, Linch DC. Lymphocytosis is it leukaemia and when to treat. Postgraduate Medical Journal. 1988; 64(747): 42-7. [View at Publisher] [DOI:10.1136/pgmj.64.747.42] [PubMed] [Google Scholar]
3. Swerdlow SH, Campo E, Pileri SA, Lee Harris N, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood. 2016; 127(20): 2375-90. [View at Publisher] [DOI:10.1182/blood-2016-01-643569] [PubMed] [Google Scholar]
4. Barnes PW, McFadden SL, Machin SJ, Simson E. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. Lab Hematol . 2005; 11(2): 83-90. [DOI:10.1532/LH96.05019] [PubMed] [Google Scholar]
5. Genevieve F, Galoisy AC, Bataille DM, Wagner-Ballon O, Trimoreau F, Fenneteau O, et al. Revue microscopique du frottissanguin : proposition du groupe Francophone d'hematologiecellulaire. Feuillets de Biologie. 2014;317:2-16. [View at Publisher]
6. Rose Johann. Hyperlymphocytose sanguine modérée de l'adulte :Seuilsrationnels et orientation optimale au laboratoired'hématologie [thesis]. Départementd'hématologieetd'immunologie: Angers. 2016; 53. [View at Publisher] [Google Scholar]
7. George TI. Malignant or benign leukocytosis. Hematology Am SocHematolEduc Program. 2012;2012:475-84. [DOI:10.1182/asheducation.V2012.1.475.3798515] [PubMed] [Google Scholar]
8. ChaicharoenTantanate, CherdsakKlinbua. Performance Evaluation of High Fluorescence Lymphocyte Count: Comparability to Atypical Lymphocyte Count and Clinical Significance. Laboratory Medicine 2018;49(4):362-368. doi: 10.1093/labmed/lmy030. [View at Publisher] [DOI:10.1093/labmed/lmy030] [PubMed] [Google Scholar]
9. Seghezzi M, Buoro S, Previtali G, Moioli V, Manenti B, Simon-Lopez R et al. A preliminary proposal for quality control assessement and harmonizaton for leucocytes morphology.Structural parameters (Cell population data parameters).Journal of Medical biochemistry. 2018;37(4):486-98.doi: 10.2478/jomb-2018-0005 [DOI:10.2478/jomb-2018-0005] [PubMed] [Google Scholar]
10. Sun P, Kowalski EM, Cheng CK, Shawwa A, Liwski RS, Juskevicius R. Predictive significance of absolute lymphocyte count and morphology in adults with a new onset peripheral blood lymphocytosis. Journal of Clinical Pathology. 2014; 67(12): 1062-6. [DOI:10.1136/jclinpath-2014-202545] [PubMed] [Google Scholar]
11. Andrews JM, Cruser DL, Myers JB, Fernelius CA, Holm MT, Waldner DL. Using peripheral smear review, age and absolute lymphocyte count as predictors of abnormal peripheral blood lymphocytoses diagnosed by flow cytometry. Leuk Lymphoma. 2008; 49(9): 1731-7. [View at Publisher] [DOI:10.1080/10428190802251787] [PubMed] [Google Scholar]
12. Jean A, Boutet C, Lenormand B, Callat MP, Buchonnet G, Leclerc C, et al. Combination of cellular population data and CytoDiffTM analyses for the diagnosis of lymphocytosis. Clinical Chemistryand Laboratory Medicine. 2011; 49(11): 1861-1868. [View at Publisher] [DOI:10.1515/cclm.2011.680] [PubMed] [Google Scholar]
13. Tseng V, Morgan AS, Leith CP, Yang DT. Efficient assessment of peripheral blood lymphocytosis in adults: developing new thresholds for blood smear review by pathologists. Clinical Chemistry and Laboratory Medicine 2014; 52(12): 1763-1770. [View at Publisher] [DOI:10.1515/cclm-2014-0320] [PubMed] [Google Scholar]
14. Oberley MJ, Fitzgerald S, Yang DT, Morgan A, Johnson J, Leith C. Value-based flow testing of chronic lymphoproliferative disorders: a quality improvement project to develop an algorithm to streamline testing and reduce costs. American Journal of Clinical Pathology. 2014; 142(3): 411-8. [View at Publisher] [DOI:10.1309/AJCP0SWZJ6GBDHPF] [PubMed] [Google Scholar]
15. Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M et al. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica. 2011; 96(2): 277-83.
https://doi.org/10.3324/haematol.2010.030189 [View at Publisher] [DOI:10.3324/haematol.2010.030189.] [PubMed] [Google Scholar]
16. Xie H, Wu Y, Cui W. Correlation between the cell population in the automated hematology analyzer high-fluorescence region and atypical lymphocyte flags. Journal of Clinical Laboratory Analysis. 2018;32(5):e22374. doi: 10.1002/jcla.22374. [View at Publisher] [DOI:10.1002/jcla.22374] [PubMed] [Google Scholar]
17. Brisou G, Manzoni D, Dalle S, Felman P, Morel D, Boubaya M, et al. Alarms and parameters generated by hematology analyzer: new tools to predict and quantify circulating Sezary cells. Journal of Clinical Laboratory Analysis. 2015;29(2):153 61. doi: 10.1002/jcla.21744 [View at Publisher] [DOI:10.1002/jcla.21744] [PubMed] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.